Clinical OPC

by EuroMedica · capsule · 60 capsules

  • On the market (NIH)
  • UPC 3 67703 83606 1
  • DSLD label 52923
  • Serving 1 capsule
  • 60 servings

Clinical OPC by EuroMedica lists one ingredient: 150 mg of french grape (vitis vinifera L.) seed extract per serving of 1 capsule. Its current label entered the NIH Dietary Supplement Label Database on October 22, 2015.

What is in Clinical OPC?

Each row as the label prints it, per serving of 1 capsule. The capsule beside an amount places it among every product in the NIH database that lists the same ingredient: the bar is the middle half of their amounts, the line in it the median, the whiskers the 10th and 90th percentiles; the green tick is the FDA Daily Value and the red dashed tick the adult upper limit (IOM).

Clinical OPC: Supplement Facts rows against the market (DSLD label 52923, January 2026 release)
IngredientAmount% DVAmong products listing it
French Grape (Vitis vinifera L.) seed extractas OPCs, PolyphenolsFrench Grape (Vitis vinifera L.) seed extract (Form: standardized to contain {greater than or equal to} 99% Polyphenols, and {greater than or equal to} 80% OPCs) PlantPart: seed Genus: Vitis Species: vinifera Classifier: L. Note: Tannin free150 mgGrape in Clinical OPC against 1,900 products150 mg per serving; the middle half of products list 25 mg to 100 mg, the median 50 mg.150 mg

Higher than 77% of 1,900 products listing grape (median 50 mg).

Source: NIH ODS Dietary Supplement Label Database, label 52923 (entered October 22, 2015), version 9.4.0. See the label on DSLD. Amounts are what the maker printed; DSLD does not test products. Daily Values: the FDA's Daily Value page.

Is that a lot?

Every amount on this label with a position sits within the middle 80% of the products that list the same ingredient.

The NIH database records one serving a day from the label's directions; its % Daily Values are for adults and children 4 or more years of age. The directions as printed are further down this page.

The Tolerable Upper Intake Level is the most of a nutrient per day, from food, water and supplements together, that is likely to pose no risk for almost all adults (Institute of Medicine, 2011). It does not apply under medical supervision. This page compares labels; it is not medical advice.

Sources: amounts from the DSLD label; Daily Values from 21 CFR 101.9(c)(8)(iv); adult upper limits from the Institute of Medicine's DRI summary tables (2011). How positions are computed.

Which products have the closest formulas?

6 products list the very same ingredients; the nearest amounts come first.

Source: ingredient lists of every product's current label in DSLD (version 9.4.0); similarity weights each shared ingredient by how rare it is.

What does the label say about taking it?

Quoted from the label as DSLD transcribed it: the maker's words, including any claim about what the product does, which the FDA has not evaluated and PlainVitamins does not endorse.

Directions
Recommendations: 1 capsule daily, or as recommended by your healthcare professional.
Warnings
If pregnant or nursing, consult a healthcare practitioner before use.
Allergens and what it does not contain
High Absorption – Tannin Free Grape Seed Extract
No sugar, salt, yeast, wheat, gluten, corn, soy, dairy products, artificial coloring, artificial flavoring, or artificial preservatives. NON-GMO

Source: label statements in DSLD label 52923.

What else is on the label?

Other ingredients: Cellulose powder, Hydroxypropyl Methylcellulose, Silicon Dioxide, Vegetable Source Magnesium Stearate.

Seals and symbols as the label prints them (the maker's; a certifier's own list confirms a seal): V VEGAN.

How many labels does Clinical OPC have?

One label is on file, entered on October 22, 2015.

  1. Label 52923 (current) Entered October 22, 2015 · on the market · 60 capsules · UPC 3 67703 83606 1

Source: DSLD label entry and market events, version 9.4.0 (labels entered through September 25, 2025).

Who makes it?

The label names EuroMedica (distributor), Green Bay, WI. All EuroMedica products.

Where next?